This contradicts serological studies in a murine transgenic model for HCC expressing viral oncogene SV40-Tag that reported an increased level of CP in serum [130], as well as observations in the serum of patients with solid tumors of the lung, breast, head/neck, and gastrointestinal tract [131]. This evidence concerns the gene CP and hepatocellular carcinoma.